Top Small Cap Stocks To Keep An Eye On – February 12th

Vale, Direxion Daily MU Bull 2X Shares, Cortexyme, Direxion Daily PLTR Bear 1X Shares, Spring Valley Acquisition, Tower Semiconductor, and Rapt Therapeutics are the seven Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of companies with relatively small market capitalizations—commonly in the roughly $300 million to $2 billion range, though exact cutoffs vary by index or provider. They often offer higher growth potential but typically come with greater price volatility and liquidity and business risk compared with larger, more established firms. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Vale (VALE)

Vale S.A., together with its subsidiaries, produces and sells iron ore and iron ore pellets for use as raw materials in steelmaking in Brazil and internationally. The company operates through Iron Solutions and Energy Transition Materials segments. The Iron Solutions segment produces and extracts iron ore and pellets, manganese, and other ferrous products; and provides related logistic services.

Direxion Daily MU Bull 2X Shares (MUU)

Cortexyme (CRTX)

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection.

Direxion Daily PLTR Bear 1X Shares (PLTD)

Spring Valley Acquisition (SV)

Tower Semiconductor (TSEM)

Tower Semiconductor Ltd., an independent semiconductor foundry, focus on specialty process technologies to manufacture analog intensive mixed-signal semiconductor devices in Israel, the United States, Japan, Europe, and internationally. It provides various customizable process technologies, including SiGe, BiCMOS, mixed signal/CMOS, RF CMOS, CMOS image sensor, integrated power management, and MEMS.

Rapt Therapeutics (RAPT)

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues.